Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1467 total)
-
Creator: Mbala-Kingebeni, Placide, Catherine Pratt, Mbusa Mutafali-Ruffin, Matthias G. Pauthner, Faustin Bile, Antoine Nkuba-Ndaye, Allison Black, Eddy Kinganda-Lusamaki, Martin Faye, Amuri Aziza, Moussa M. Diagne, Daniel Mukadi, Bailey White, James Hadfield,…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-31
Description: During the 2018–2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus–based vaccine expressing a ZEBOV… -
Creator: Boulanger, M., E. Molina, K. Wang, T. Kickler, Y. Xu, and B. T. Garibaldi.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-31
Description: Cytokines seen in severe COVID-19 are associated with proliferation, differentiation, and survival of plasma cells. Plasma cells are not routinely found in peripheral blood, though may produce virus-neutralizing antibodies in COVID-19 later in the… -
Creator: Wiley, Z., K. Ross-Driscoll, Z. Wang, L. Smothers, A. K. Mehta, and R. E. Patzer.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-04-02
Description: Since the introduction of remdesivir and dexamethasone for severe COVID-19 treatment, few large multi-hospital system US studies have described clinical characteristics and outcomes of minority COVID-19 patients who present to the emergency… -
Creator: the mRNA-1273 Study Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-06
Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19). -
Creator: Adelman, M. W., D. R. Bhamidipati, A. C. Hernandez-Romieu, A. Babiker, M. H. Woodworth, C. Robichaux, D. J. Murphy, S. C. Auld, C. S. Kraft, and J. T. Jacob.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-06
Description: Hospitalized patients, particularly those who are critically ill, are at risk for ‘secondary’ infections(1, 2). Initial reports of patients hospitalized with COVID-19 indicate that 10-33% develop bacterial pneumonia(3, 4) and 2-6% develop bloodstream… -
Creator: Ridder, M. P., K. D. Paladino, J. J. Lowe, and M. E. Rupp.
Subject: Infection Control
Item Type: Publication
Date Last Updated: 2021-04-06
Description: Prior outbreaks of respiratory viruses have demonstrated the need for adequate personal protective equipment (PPE) for healthcare workers, particularly filtering facepiece respirators (FFR). Due to shortfalls of PPE during the SARS CoV-2 pandemic,… -
Creator: the Siren Study Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-09
Description: Increased understanding of whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to investigate whether antibodies against SARS-CoV-2 were associated with a decreased… -
Creator: Schultz, Nina H., Ingvild H. Sørvoll, Annika E. Michelsen, Ludvig A. Munthe, Fridtjof Lund-Johansen, Maria T. Ahlen, Markus Wiedmann, Anne-Hege Aamodt, Thor H. Skattør, Geir E. Tjønnfjord, and Pål A. Holme.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-09
Description: We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). -
Creator: Greinacher, Andreas, Thomas Thiele, Theodore E. Warkentin, Karin Weisser, Paul A. Kyrle, and Sabine Eichinger.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-09
Description: Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1… -
Creator: Frampton, Dan, Tommy Rampling, Aidan Cross, Heather Bailey, Judith Heaney, Matthew Byott, Rebecca Scott, Rebecca Sconza, Joseph Price, Marios Margaritis, Malin Bergstrom, Moira J. Spyer, Patricia B. Miralhes, Paul Grant, Stuart Kirk, Chris Valerio,…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-12
Description: Emergence of variants with specific mutations in key epitopes in the spike protein of SARS-CoV-2 raises concerns pertinent to mass vaccination campaigns and use of monoclonal antibodies. We aimed to describe the emergence of the B.1.1.7 variant of…